Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;43(6):585-9.
doi: 10.1038/ng.835. Epub 2011 May 15.

Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations

Brian J O'Roak  1 , Pelagia Deriziotis, Choli Lee, Laura Vives, Jerrod J Schwartz, Santhosh Girirajan, Emre Karakoc, Alexandra P Mackenzie, Sarah B Ng, Carl Baker, Mark J Rieder, Deborah A Nickerson, Raphael Bernier, Simon E Fisher, Jay Shendure, Evan E Eichler
Affiliations

Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations

Brian J O'Roak et al. Nat Genet. 2011 Jun.

Erratum in

  • Nat Genet. 2012 Apr;44(4):471

Abstract

Evidence for the etiology of autism spectrum disorders (ASDs) has consistently pointed to a strong genetic component complicated by substantial locus heterogeneity. We sequenced the exomes of 20 individuals with sporadic ASD (cases) and their parents, reasoning that these families would be enriched for de novo mutations of major effect. We identified 21 de novo mutations, 11 of which were protein altering. Protein-altering mutations were significantly enriched for changes at highly conserved residues. We identified potentially causative de novo events in 4 out of 20 probands, particularly among more severely affected individuals, in FOXP1, GRIN2B, SCN1A and LAMC3. In the FOXP1 mutation carrier, we also observed a rare inherited CNTNAP2 missense variant, and we provide functional support for a multi-hit model for disease risk. Our results show that trio-based exome sequencing is a powerful approach for identifying new candidate genes for ASDs and suggest that de novo mutations may contribute substantially to the genetic etiology of ASDs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evaluation of de novo mutations by simulation, proband severity, and family 12817. a,b We compared the mean Grantham (black x-axis) and GERP scores (black y-axis) of the 10 proband de novo protein-changing substitutions to 20 HapMap control samples by building a distribution of the mean values of 10 randomly selected common or private variants over 1000 trials. Splice-site and nonsense events were given a maximum Grantham score (215) and indels were not included in the simulation. Histograms show the relative frequency (blue axes) of each distribution. Points show the proband variants, with variants from the same individual highlighted (blue=13708.p1, red=12499.p1). Proband mean values, GERP: 4.349 and Grantham: 104.3. *FOXP1 not included in proband mean values. a, Control common variants (GERP: p<0.001, Grantham: p=0.015). b, Control rare variants (GERP: p=0.026, Grantham: p=0.098). c,d We evaluated the disease severity of the mutation carriers 12817.p1-FOXP1 (brown), 12681.p1-GRIN2B (green), 12499-SCN1A (blue) and 11666.p1-LAMC3 (red). c, Box and whisker plot of Full Scale Intelligence Quotient (FSIQ) values. d, Box and whisker plot of Calibrated Severity Scores (CSS) based on the Autism Diagnostic Observation Schedule (ADOS). Data were available for 19/20 probands; CSS were estimated for two probands based on ADOS module 4 data. e, Pedigree for 12817 showing chromatogram traces surrounding FOXP1 (top) and CNTNAP2 (bottom) mutation events. Proband carries a de novo single-base (+A relative to mRNA) frameshifting mutation p.A339SfsX4 in FOXP1 and an inherited missense variant p.H275A in CNTNAP2.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bailey A, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25:63–77. - PubMed
    1. O’Roak BJ, State MW. Autism genetics: strategies, challenges, and opportunities. Autism Research. 2008;1:4–17. - PubMed
    1. Girirajan S, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet. 2010;42:203–9. - PMC - PubMed
    1. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008;9:341–55. - PMC - PubMed
    1. Sebat J, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445–9. - PMC - PubMed

Publication types